Report cover image

Plastic Resin Market

Publisher Grand View Research
Published Jan 22, 2026
Length 120 Pages
SKU # GV20873249

Description

Plastic Resin Market Summary

The global plastic resin market size was estimated at USD 832.86 billion in 2025 and is projected to reach USD 1,140.30 billion by 2033, growing at a CAGR of 3.9% from 2026 to 2033. Capacity additions and feedstock availability are key drivers shaping the global market, as they directly influence supply, cost structures, and regional competitiveness.

Trends in raw material availability for the market are being shaped by feedstock supply, price volatility, and a strong push toward circular and lower-carbon inputs. Producers continue to balance ethane, LPG, and naphtha feedstock mixes to optimize crackers for cost and product slate. North American ethane-advantaged crackers produce ethylene at a lower cost, whereas Europe and parts of Asia remain more naphtha-dependent and therefore more vulnerable to fluctuations in oil prices.

Global Plastic Resin Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the plastic resin market report based on product, applications, and region:
  • Product Outlook (Volume, Kilotons; Revenue, USD Million, 2021 - 2033)
  • Crystalline
  • Epoxy
  • Polyethylene
  • Polyethylene Terephthalate (PET)
  • Polypropylene
  • Non-crystalline
  • Polyvinyl Chloride (PVC)
  • Polystyrene (PS)
  • Acrylonitrile butadiene styrene (ABS)
  • Polymethyl Methacrylate (PMMA)
  • Engineering Plastic
  • Nylon
  • Polybutylene Terephthalate (PBT)
  • Polycarbonate (PC)
  • Polyurethane (PU)
  • Polyphenylene Oxide (PPO)
  • Polyamide
  • Super Engineering Plastic
  • Polyphenylene Sulfide (PPS)
  • Polyether Ether Ketone (PEEK)
  • Polysulfone (PSU)
  • Polyphenylsulfone (PPSU)
  • Liquid Crystal Polymer (LCP)
  • Other Products
  • Applications Outlook (Volume, Kilotons; Revenue, USD Million, 2021 - 2033)
  • Packaging
  • Food
  • Beverage
  • Medical
  • Retail
  • Other packaging applications
  • Automotive
  • Construction
  • Electrical & Electronics
  • OA Equipment and Home Appliances
  • Electronic Materials
  • Other E&E applications
  • Logistics
  • Consumer Goods
  • Textiles & Clothing
  • Clothing
  • Industrial use
  • Other textile & clothing applications
  • Furniture & Bedding
  • Agriculture
  • Medical Devices
  • Other applications
  • Regional Outlook (Volume, Kilotons; Revenue, USD Million, 2021 - 2033)
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Poland
  • Spain
  • China
  • Asia
  • India
  • Japan
  • South Korea
  • Singapore
  • Malaysia
  • Thailand
  • Indonesia
  • Vietnam
  • Australia
  • Pacific
  • Central & South America
  • Brazil
  • Argentina
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Oman
Please note The report will be delivered in 2-3 business days upon order notification.

Table of Contents

120 Pages
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Segment Definitions
1.2. Estimates and Forecast Timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. GVR’s Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.4.5. Details of Primary Research
1.4.6. Research Assumption
1.5. Information or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Data Visualization
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.8. Objectives
1.8.1. Objective - 1
1.8.2. Objective - 2
1.8.3. Objective - 3
1.9. List of Secondary Sources
1.10. List of Secondary Sources
Chapter 2. Executive Summary
2.1. U.S. CPAP Devices Market
2.1.1. Market Snapshot
2.1.2. Segment Snapshot
2.1.2.1. Connectivity segment outlook
2.1.2.2. End Use segment outlook
2.1.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Trends and Outlook
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.1.1. Rising incidence of obstructive sleep apnea (OSA)
3.3.1.2. Technological advancements
3.3.1.3. Supportive initiatives by government and private organizations for CPAP devices
3.3.2. Market Restraint Analysis
3.3.2.1. Product recalls & failure
3.3.2.2. Complex regulatory framework pertaining to CPAP devices
3.3.3. Market Opportunity Analysis
3.3.3.1. Growing adoption of CPAP devices in home care settings
3.3.4. Market Challenges Analysis
3.3.4.1. Regulatory and reimbursement challenges
3.4. U.S. CPAP Devices Market Analysis Tools: PESTEL
3.4.1. Political & Legal
3.4.2. Economic & Social
3.4.3. Technology
3.4.4. Environment
3.5. U.S. CPAP Market Analysis Tools: Porter's
Chapter 4. U.S. CPAP Devices Market: Connectivity Estimates & Trend Analysis
4.1. U.S. CPAP Devices Market: Connectivity Movement Analysis
4.2. U.S. CPAP Devices Market: Connectivity Segment Dashboard
4.3. Connectivity Movement & Market Share Analysis, 2025 & 2033
4.4. U.S. Connectivity Market Estimates & Forecast, by Connectivity
4.5. Connected
4.5.1. Market Estimates & Forecast, 2021 - 2033 (USD Million) (000' Units)
4.5.2. Bluetooth-Connected CPAP
4.5.2.1. Market Estimates & Forecast, 2021 - 2033 (USD Million) (000’ Units)
4.5.3. Wi-Fi & Cellular Connected CPAP
4.5.3.1. Market Estimates & Forecast, 2021 - 2033 (USD Million) (000’ Units)
4.5.4. Hybrid-Connected
4.5.4.1. Market Estimates & Forecast, 2021 - 2033 (USD Million) (000’ Units)
4.6. Non-Connected
4.6.1. Market Estimates & Forecast, 2021 - 2033 (USD Million) (000’ Units)
Chapter 5. U.S. CPAP Devices Market: End Use Estimates & Trend Analysis
5.1. U.S. CPAP Devices Market: End Use Movement Analysis
5.2. U.S. CPAP Devices Market: End Use Segment Dashboard
5.3. End Use Movement & Market Share Analysis, 2025 & 2033
5.4. U.S. CPAP Devices Market Estimates & Forecast, by End Use
5.5. Home Care Settings
5.5.1. Market Estimates & Forecast, 2021 - 2033 (USD Million) (000’ Units)
5.6. Hospitals & Clinics
5.6.1. Market Estimates & Forecast, 2021 - 2033 (USD Million) (000’ Units)
5.7. Others (Long-Term Care Facilities, etc.)
5.7.1. Market Estimates & Forecast, 2021 - 2033 (USD Million) (000’ Units)
Chapter 6. Competitive Landscape
6.1. Company Categorization
6.2. Strategies of Market Players for Entry and Exit and Their Impact on Market Competitors
6.3. Company Market Position Analysis
6.4. Company Share Analysis, from 2012 to 2025 (%)
6.5. Company Profiles/Listing
6.5.1. ResMed
6.5.1.1. Overview
6.5.1.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2025)
6.5.1.3. Product benchmarking
6.5.1.4. Strategic initiatives
6.5.2. Koninklijke Philips N.V.
6.5.2.1. Overview
6.5.2.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2025)
6.5.2.3. Product benchmarking
6.5.2.4. Strategic initiatives
6.5.3. Fisher & Paykel Healthcare Limited
6.5.3.1. Overview
6.5.3.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2025)
6.5.3.3. Product benchmarking
6.5.3.4. Strategic initiatives
6.5.4. React Health (3B Medical)
6.5.4.1. Overview
6.5.4.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2025)
6.5.4.3. Product benchmarking
6.5.4.4. Strategic initiatives
6.5.5. Löwenstein Medical
6.5.5.1. Overview
6.5.5.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2025)
6.5.5.3. Product benchmarking
6.5.5.4. Strategic initiatives
6.5.6. BMC Medical
6.5.6.1. Overview
6.5.6.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2025)
6.5.6.3. Product benchmarking
6.5.6.4. Strategic initiatives
6.5.7. Wellell (Apex Medical)
6.5.7.1. Overview
6.5.7.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2025)
6.5.7.3. Product benchmarking
6.5.7.4. Strategic initiatives
6.5.8. Armstrong Medical
6.5.8.1. Overview
6.5.8.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2025)
6.5.8.3. Product benchmarking
6.5.8.4. Strategic initiatives
6.5.9. Breas Medical
6.5.9.1. Overview
6.5.9.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2025)
6.5.9.3. Product benchmarking
6.5.9.4. Strategic initiatives
6.5.10. SEFAM
6.5.10.1. Overview
6.5.10.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2025)
6.5.10.3. Product benchmarking
6.5.10.4. Strategic initiatives
6.5.11. Transcend Inc. (Somnetics International, Inc.)
6.5.11.1. Overview
6.5.11.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2025)
6.5.11.3. Product benchmarking
6.5.11.4. Strategic initiatives
6.5.12. Trudell Medical (Vyaire)
6.5.12.1. Overview
6.5.12.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2025)
6.5.12.3. Product benchmarking
6.5.12.4. Strategic initiatives
6.5.13. Medical Depot, Inc. dba Drive DeVilbiss Healthcare
6.5.13.1. Overview
6.5.13.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2025)
6.5.13.3. Product benchmarking
6.5.13.4. Strategic initiatives
6.5.14. Invacare Corporation
6.5.14.1. Overview
6.5.14.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2025)
6.5.14.3. Product benchmarking
6.5.14.4. Strategic initiatives
6.5.15. Apria Healthcare Group LLC
6.5.15.1. Overview
6.5.15.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2025)
6.5.15.3. Product benchmarking
6.5.15.4. Strategic initiatives
6.5.16. Rotech Healthcare Inc.
6.5.16.1. Overview
6.5.16.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2025)
6.5.16.3. Product benchmarking
6.5.16.4. Strategic initiatives
6.5.17. Others
6.5.17.1. Overview
6.5.17.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2025)
6.5.17.3. Product benchmarking
6.5.17.4. Strategic initiatives
6.6. U.S CPAP Devices: Sales Model Composition (Rental vs. Direct Purchase), 2020 - 2024
6.7. U.S. PAP Device DME Distributor-Level Profiles
6.7.1. Lincare Holdings Inc.
6.7.1.1. Estimated CPAP-related revenue and units (2020 - 2024E)
6.7.1.2. % contribution of each manufacturer within that DME
6.7.1.3. Sales model mix (% rental vs. direct)
6.7.1.4. Key partnerships and manufacturer
6.7.1.5. Notable strategic changes post-Philips recall
6.7.2. Rotech Healthcare Inc.
6.7.2.1. Estimated CPAP-related revenue and units (2020 - 2024E)
6.7.2.2. % contribution of each manufacturer within that DME
6.7.2.3. Sales model mix (% rental vs. direct)
6.7.2.4. Key partnerships and manufacturer
6.7.2.5. Notable strategic changes post-Philips recall
6.7.3. AdaptHealth
6.7.3.1. Estimated CPAP-related revenue and units (2020 - 2024E)
6.7.3.2. % contribution of each manufacturer within that DME
6.7.3.3. Sales model mix (% rental vs. direct)
6.7.3.4. Key partnerships and manufacturer
6.7.3.5. Notable strategic changes post-Philips recall
6.7.4. Aeroflow Health
6.7.4.1. Estimated CPAP-related revenue and units (2020 - 2024E)
6.7.4.2. % contribution of each manufacturer within that DME
6.7.4.3. Sales model mix (% rental vs. direct)
6.7.4.4. Key partnerships and manufacturer
6.7.4.5. Notable strategic changes post-Philips recall
6.7.5. CPAP.com
6.7.5.1. Estimated CPAP-related revenue and units (2020 - 2024E)
6.7.5.2. % contribution of each manufacturer within that DME
6.7.5.3. Sales model mix (% rental vs. direct)
6.7.5.4. Key partnerships and manufacturer
6.7.5.5. Notable strategic changes post-Philips recall
6.7.6. AHOM
6.7.6.1. Estimated CPAP-related revenue and units (2020 - 2024E)
6.7.6.2. % contribution of each manufacturer within that DME
6.7.6.3. Sales model mix (% rental vs. direct)
6.7.6.4. Key partnerships and manufacturer
6.7.6.5. Notable strategic changes post-Philips recall
6.7.7. The CPAP Shop
6.7.7.1. Estimated CPAP-related revenue and units (2020 - 2024E)
6.7.7.2. % contribution of each manufacturer within that DME
6.7.7.3. Sales model mix (% rental vs. direct)
6.7.7.4. Key partnerships and manufacturer
6.7.7.5. Notable strategic changes post-Philips recall
6.7.8. Sleep Direct
6.7.8.1. Estimated CPAP-related revenue and units (2020 - 2024E)
6.7.8.2. % contribution of each manufacturer within that DME
6.7.8.3. Sales model mix (% rental vs. direct)
6.7.8.4. Key partnerships and manufacturer
6.7.8.5. Notable strategic changes post-Philips recall
6.7.9. Edgepark Medical Supplies
6.7.9.1. Estimated CPAP-related revenue and units (2020 - 2024E)
6.7.9.2. % contribution of each manufacturer within that DME
6.7.9.3. Sales model mix (% rental vs. direct)
6.7.9.4. Key partnerships and manufacturer
6.7.9.5. Notable strategic changes post-Philips recall
6.7.10. Apria Healthcare
6.7.10.1. Estimated CPAP-related revenue and units (2020 - 2024E)
6.7.10.2. % contribution of each manufacturer within that DME
6.7.10.3. Sales model mix (% rental vs. direct)
6.7.10.4. Key partnerships and manufacturer
6.7.10.5. Notable strategic changes post-Philips recall

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us